The Dana-Farber Cancer Institute has announced a $20 million gift from the Saverin family to establish the Saverin Breast Cancer Research Fund.
The largest individual gift in support of breast cancer research in Dana-Farber history will fund research on stage IV metastatic breast cancer — which is treatable but currently incurable — with the goal of achieving significant advances in treatment and eventual cures over the next five years. Under the direction of Eric Winer, senior vice president for medical affairs, chief of the Breast Oncology Division in the Susan F. Smith Center for Women's Cancers, and the Thompson Chair in Breast Cancer Research at Dana-Farber, the fund will support studies focused on resistance to hormonal treatments and targeted therapies.
The first major gift to the institute from the family will count toward the center's comprehensive fundraising campaign, which currently is in its quiet phase.
"The Saverin family's foresight will allow us to tackle the unsolved challenges by building on the advances we have already forged, and to develop entirely new strategies," said Winer. "Their exceptional generosity provides resources we need to further metastatic breast cancer research that is underway, and, more importantly, to open bold avenues of investigation."